Clinical Trials Directory

Trials / Completed

CompletedNCT02555774

Efficacy of Cognitive Training in Subjective Memory Impairment

A Prospective, Three-arm, Parallel Design, Controlled Trial to Assess Efficacy of Cognitive Training in Subjective Memory Impairment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
65 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
55 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study evaluates the efficacy of cognitive training in subjects with subjective memory impairment. The first group will receive cognitive training and lifestyle modification in combination, the second group will receive only lifestyle modification, and the third group will receive no intervention.

Detailed description

Subjective memory impairment is currently thought to be a risky state of progression to Alzheimer's disease. This study aims to confirm whether cognitive training in subjective memory impairment would show improvement in the subjective and objective cognition. We include subjects with normal cognition but complained subjective feeling of memory decline and conduct cognitive training programs combined with lifestyle modifications for 3 months. We evaluate the neuropsychological tests and questionnaires about subjective improvement after 3 months of interventions.

Conditions

Interventions

TypeNameDescription
BEHAVIORALcognitive trainingcognitive training is held 2 times a week for 3 months, 90 minutes per 1 session. It includes cognitive exercise of multiple cognitive domains such as memory, attention, calculation, executive function and visuospatial function.
BEHAVIORALlifestyle modificationeducation about lifestyle modification is done by investigators at the first day of the trial and the investigators conduct weekly phone call to participants to educate the lifestyle modifications

Timeline

Start date
2014-05-01
Primary completion
2015-11-01
Completion
2016-02-01
First posted
2015-09-22
Last updated
2018-08-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02555774. Inclusion in this directory is not an endorsement.